Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

Ganesh Pawar Article rating: 4.0

The market opened flat on July 02, 2021, overall volumes in futures & options currently stand at 8,82,27,534 contracts with a turnover of Rs. 84,09,744.70 crore.

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

Ganesh Pawar Article rating: 4.7

The market opened flat on July 02, 2021, overall volumes in futures & options currently stand at 8,82,27,534 contracts with a turnover of Rs. 84,09,744.70 crore.

Lupin announces USFDA approval of supplemental new drug for treating Trichomoniasis
Lupin announces USFDA approval of supplemental new drug for treating Trichomoniasis

Lupin announces USFDA approval of supplemental new drug for treating Trichomoniasis

Ganesh V Article rating: 5.0

Lupin Limited announced on Thursday that United States Food & Drug Administration (USFDA) has approved the company’s supplemental new drug application (sNDA) to expand the use of Solosec (Secnidazole) to include the treatment of Trichomoniasis in adults.

Edelweiss Group to divest entire stake in Edelweiss Gallagher Insurance Brokers Ltd
Edelweiss Group to divest entire stake in Edelweiss Gallagher Insurance Brokers Ltd

Edelweiss Group to divest entire stake in Edelweiss Gallagher Insurance Brokers Ltd

Shruti Dahiwal Article rating: 4.3

Edelweiss Group, a leading investment & financial services company (headquartered in Mumbai) announced today, the sale of its complete stake in Edelweiss Gallagher Insurance Brokers Ltd (EGIBL) to Gallagher, a US-based insurance brokerage and risk management services firm. 

Speciality stocks continue to rise on higher demand and lower supply
Speciality stocks continue to rise on higher demand and lower supply

Speciality stocks continue to rise on higher demand and lower supply

The Indian speciality chemicals industry is expected to deliver a compound annual growth rate (CAGR) of 12.4 per cent over the next five years

Abhinav Lahoti Article rating: 4.3

Demand for speciality chemicals has continued to rise regularly in the past one year, which has led to increase in the prices of these chemicals. The easing of lockdown restrictions around the world has led to improvement in the outlook for the sector.

JSW Steel receives GreenPro Ecolabel certification for JSW Neosteel
JSW Steel receives GreenPro Ecolabel certification for JSW Neosteel

JSW Steel receives GreenPro Ecolabel certification for JSW Neosteel

GreenPro assigns credits to the environment-friendly manufacturing processes; thus, recognising JSW Steel as a sustainable manufacturer.

Apurva Joshi Article rating: 5.0

JSW Steel Limited has informed the bourses that it has received GreenPro Ecolabel certification for JSW Neosteel, the company's brand of TMT rebars. It is one of the first steel companies in India to get this certificate. 

Alembic Pharmaceuticals announces USFDA final approval for Nitrofurantoin capsules
Alembic Pharmaceuticals announces USFDA final approval for Nitrofurantoin capsules

Alembic Pharmaceuticals announces USFDA final approval for Nitrofurantoin capsules

Ganesh V Article rating: 3.5

Alembic Pharmaceuticals Limited today announced that it has received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Nitrofurantoin capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg. 

RSS
First22922293229422952297229923002301Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR